• Loading stock data…

NANOBIOTIX Announces First Patient Enrolled in NANORAY-312 Global Phase III Registrational Study of NBTXR3 in Head and Neck Cancer

[#item_full_content]

Print Friendly, PDF & Email
Spread the word